
-
SONENDO INC NEW YORK STOCK EXCHANGE INC.:SONX Sonendo is a company focused on saving teeth from tooth decay, the most prevalent chronic disease globally. Sonendo has developed the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The GentleWave System, the first and only FDA-cleared system for root canal therapy, or RCT, that employs a sterilized, single-use Procedure Instrument, to transform RCT by addressing the limitations of conventional methods. The system utilizes its proprietary mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure.
Location: | Website: sonendo.com | Industry: Surgical and Medical Instrument Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
3.275M
Cash
17.28M
Avg Qtr Burn
-7.806M
Short % of Float
0.35%
Insider Ownership
12.91%
Institutional Own.
12.85%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|